Td Asset Management Inc Zentalis Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 106,080 shares of ZNTL stock, worth $332,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares

106,080

Previous 102,880 3.11%

Holding current value

$332,030

Previous $420,000 7.38%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$2.9 - $4.57 $9,280 - $14,624	3,200 Added 3.11%	106,080 $389,000
Q2 2024 Aug 02, 2024	SELL	$4.09 - $16.13 $637,786 - $2.52 Million	-155,938 Reduced 60.25%	102,880 $420,000
Q1 2024 May 08, 2024	BUY	$10.83 - $16.49 $743,479 - $1.13 Million	68,650 Added 36.1%	258,818 $4.08 Million
Q4 2023 Feb 12, 2024	BUY	$9.84 - $20.13 $92,496 - $189,222	9,400 Added 5.2%	190,168 $2.88 Million
Q3 2023 Oct 27, 2023	BUY	$19.63 - $28.29 $1.53 Million - $2.21 Million	78,140 Added 76.14%	180,768 $3.63 Million
Q2 2023 Aug 09, 2023	BUY	$17.41 - $30.05 $346,824 - $598,626	19,921 Added 24.09%	102,628 $2.9 Million
Q3 2022 Nov 07, 2022	BUY	$20.23 - $31.73 $2,023 - $3,173	100 Added 0.12%	82,707 $1.78 Million
Q2 2022 Aug 04, 2022	SELL	$17.91 - $52.25 $417,231 - $1.22 Million	-23,296 Reduced 22.0%	82,607 $2.32 Million
Q1 2022 May 10, 2022	SELL	$41.58 - $80.89 $487,733 - $948,839	-11,730 Reduced 9.97%	105,903 $4.89 Million
Q4 2021 Feb 10, 2022	BUY	$66.92 - $84.79 $1.77 Million - $2.24 Million	26,375 Added 28.9%	117,633 $9.89 Million
Q3 2021 Nov 09, 2021	BUY	$46.83 - $73.5 $435,144 - $682,962	9,292 Added 11.34%	91,258 $6.08 Million
Q2 2021 Aug 11, 2021	BUY	$37.41 - $62.25 $1.97 Million - $3.28 Million	52,751 Added 180.56%	81,966 $4.36 Million
Q1 2021 May 14, 2021	BUY	$35.69 - $52.72 $168,528 - $248,943	4,722 Added 19.28%	29,215 $1.27 Million
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $63,420 - $115,940	2,000 Added 8.89%	24,493 $1.27 Million
Q2 2020 Aug 13, 2020	BUY	$23.2 - $54.8 $521,837 - $1.23 Million	22,493 New	22,493 $1.08 Million

Others Institutions Holding ZNTL

# of Institutions

141

Shares Held

67.9M

Call Options Held

48.5K

Put Options Held

89.6K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $178M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Zentalis Pharmaceuticals, Inc. Transaction History